137 related articles for article (PubMed ID: 35658975)
1. Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529.
Wang Q; Anang S; Iketani S; Guo Y; Liu L; Katsamba PS; Shapiro L; Ho DD; Sodroski JG
Cell Rep; 2022 Jun; 39(11):110924. PubMed ID: 35658975
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.
Neerukonda SN; Wang R; Vassell R; Baha H; Lusvarghi S; Liu S; Wang T; Weiss CD; Wang W
J Virol; 2022 Sep; 96(17):e0114022. PubMed ID: 36000843
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of Furin Cleavage Site and Further SARS-CoV-2 Evolution Change the Mechanisms of Viral Entry, Infection Spread, and Cell Signaling.
Frolova EI; Palchevska O; Lukash T; Dominguez F; Britt W; Frolov I
J Virol; 2022 Aug; 96(15):e0075322. PubMed ID: 35876526
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity.
Zhang L; Jackson CB; Mou H; Ojha A; Peng H; Quinlan BD; Rangarajan ES; Pan A; Vanderheiden A; Suthar MS; Li W; Izard T; Rader C; Farzan M; Choe H
Nat Commun; 2020 Nov; 11(1):6013. PubMed ID: 33243994
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 spike protein variant binding affinity to an angiotensin-converting enzyme 2 fusion glycoproteins.
Matthews AM; Biel TG; Ortega-Rodriguez U; Falkowski VM; Bush X; Faison T; Xie H; Agarabi C; Rao VA; Ju T
PLoS One; 2022; 17(12):e0278294. PubMed ID: 36472974
[TBL] [Abstract][Full Text] [Related]
6. Impact of Genetic Variability in ACE2 Expression on the Evolutionary Dynamics of SARS-CoV-2 Spike D614G Mutation.
Huang SW; Miller SO; Yen CH; Wang SF
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374416
[TBL] [Abstract][Full Text] [Related]
7. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
[TBL] [Abstract][Full Text] [Related]
8. Stability of SARS-CoV-2 Spike G614 Variant Surpasses That of the D614 Variant after Cold Storage.
Huang SY; Kung YA; Huang PN; Chang SY; Gong YN; Han YJ; Chiang HJ; Liu KT; Lee KM; Chang CY; Chang CC; Huang CG; Shih SR
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789940
[TBL] [Abstract][Full Text] [Related]
9. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins.
Xu Y; Wu C; Cao X; Gu C; Liu H; Jiang M; Wang X; Yuan Q; Wu K; Liu J; Wang D; He X; Wang X; Deng SJ; Xu HE; Yin W
Cell Res; 2022 Jul; 32(7):609-620. PubMed ID: 35641567
[TBL] [Abstract][Full Text] [Related]
10. Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant.
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milošević M; Wenzel EV; Krstanović F; Polten S; Pribanić-Matešić M; Brizić I; Baldanti F; Hammarström L; Dübel S; Šustić A; Marcotte H; Strengert M; Protić A; Piralla A; Pan-Hammarström Q; Čičin-Šain L; Hust M
BMC Med; 2022 Mar; 20(1):102. PubMed ID: 35236358
[TBL] [Abstract][Full Text] [Related]
11. The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.
Gellenoncourt S; Saunders N; Robinot R; Auguste L; Rajah MM; Kervevan J; Jeger-Madiot R; Staropoli I; Planchais C; Mouquet H; Buchrieser J; Schwartz O; Chakrabarti LA
J Virol; 2022 Oct; 96(19):e0130122. PubMed ID: 36121299
[TBL] [Abstract][Full Text] [Related]
12. Evolution of the SARS-CoV-2 spike protein in the human host.
Wrobel AG; Benton DJ; Roustan C; Borg A; Hussain S; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ
Nat Commun; 2022 Mar; 13(1):1178. PubMed ID: 35246509
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach.
Kwarteng A; Asiedu E; Sylverken AA; Larbi A; Sakyi SA; Asiedu SO
Infect Genet Evol; 2021 Jul; 91():104815. PubMed ID: 33774178
[TBL] [Abstract][Full Text] [Related]
14. Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants.
Chen CP; Huang KA; Shih SR; Lin YC; Cheng CY; Huang YC; Lin TY; Cheng SH
Microbiol Spectr; 2022 Aug; 10(4):e0074322. PubMed ID: 35703556
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1.
Geng Q; Shi K; Ye G; Zhang W; Aihara H; Li F
J Virol; 2022 Apr; 96(8):e0024922. PubMed ID: 35343765
[TBL] [Abstract][Full Text] [Related]
16. The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types.
Daniloski Z; Jordan TX; Ilmain JK; Guo X; Bhabha G; tenOever BR; Sanjana NE
Elife; 2021 Feb; 10():. PubMed ID: 33570490
[TBL] [Abstract][Full Text] [Related]
17. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
[TBL] [Abstract][Full Text] [Related]
18. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
19. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.
Chang CW; Parsi KM; Somasundaran M; Vanderleeden E; Liu P; Cruz J; Cousineau A; Finberg RW; Kurt-Jones EA
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891350
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2's Variants of Concern: A Brief Characterization.
Scovino AM; Dahab EC; Vieira GF; Freire-de-Lima L; Freire-de-Lima CG; Morrot A
Front Immunol; 2022; 13():834098. PubMed ID: 35958548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
